One study by Rout et al. (2012) reported increased serum levels of antibodies against glutamic acid decarboxylase 65 (GAD65) in ASD and ADHD groups when compared to control subjects (GAD65-antibodies were not present in any of the healthy subjects). This evidence concerns the gene GAD2 and attention deficit-hyperactivity disorder.